Haemonetics Corporation (HAE) Debt by Year
Haemonetics Corporation carried $1.2B in long-term debt against $245.4M in cash and equivalents at the end of fiscal year 2026. Long-term debt rose 32.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Haemonetics Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HAE Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $1.2B+32.4% | $921.2M+15.5% | $797.6M+5.8% | $754.1M+34.8% | $559.4M-19.0% | $690.6M+126.0% | $305.5M-5.3% | $322.5M+442.6% | $59.4M-76.6% | $253.6M-30.4% | $364.5M-10.3% | $406.4M+3.7% | $392.1M-14.2% | $456.9M+15782.7% | $2.9M |
| Cash & Equivalents | $245.4M-20.0% | $306.8M+71.6% | $178.8M-37.1% | $284.5M+9.6% | $259.5M+34.9% | $192.3M+40.1% | $137.3M-18.9% | $169.4M-6.0% | $180.2M+29.1% | $139.6M+21.2% | $115.1M-28.3% | $160.7M-16.5% | $192.5M+7.5% | $179.1M-21.7% | $228.9M |
HAE Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $1.2B+27.0% | $1.2B+32.4% | $920.0M-24.6% | $920.4M-24.5% | $920.8M-24.4% | $921.2M+15.5% | $1.2B+42.4% | $1.2B+62.9% | $1.2B+62.2% | $797.6M+5.8% | $856.8M+13.2% | $748.7M-1.4% |
| Cash & Equivalents | $223.4M-23.7% | $245.4M-20.0% | $363.4M+13.3% | $296.4M-1.0% | $292.9M-15.0% | $306.8M+71.6% | $320.8M+65.4% | $299.3M-14.7% | $344.4M+20.5% | $178.8M-37.1% | $194.0M-13.4% | $351.0M+45.5% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Haemonetics Corporation financials
Frequently Asked Questions
What was Haemonetics Corporation's long-term debt in fiscal year 2026?
Haemonetics Corporation carried $1.2B in long-term debt against $245.4M in cash and equivalents at the end of fiscal year 2026.
How fast is Haemonetics Corporation's long-term debt growing?
Haemonetics Corporation (HAE) long-term debt rose by 32.4% year over year, from $921.2M to $1.2B in fiscal year 2026.
How has Haemonetics Corporation's long-term debt changed over the years?
Across the 15 fiscal years this page covers, Haemonetics Corporation (HAE) long-term debt went from $2.9M in fiscal year 2012 to $1.2B in fiscal year 2026.
What was Haemonetics Corporation's long-term debt in the most recent quarter?
Haemonetics Corporation (HAE) reported $1.2B in long-term debt in Q1 2027. This represents an increase of 27.0% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Haemonetics Corporation (HAE) reported on that line in every period on record.